Last reviewed · How we verify
HR021618
At a glance
| Generic name | HR021618 |
|---|---|
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- HR021618 in Moderate to Severe Pain After Abdominal Surgery (PHASE2)
- A Trial of HR021618 in Postsurgical Pain Management (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |